Braveheart Bio, Inc. · NASDAQ:BRVE
Frazier Life Sciences Public Fund, L.P. reported a 5.50% stake in Braveheart Bio, Inc. (Schedule 13G)
Event Aug 7, 2026 · Filed Aug 14, 2026
Frazier Life Sciences Public Fund, L.P. reported a 5.50% stake in Braveheart Bio, Inc., 4,976,457 shares, as a passive investor on Aug 7, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 4,976,457
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 5.50% | 4,976,457 |
| FHMLSP, L.P. | 5.50% | 4,976,457 |
| FHMLSP, L.L.C. | 5.50% | 4,976,457 |
| Frazier Life Sciences XI, L.P. | 0% | 20,361 |
| FHMLS XI, L.P. | 0% | 20,361 |
| FHMLS XI, L.L.C. | 0% | 20,361 |
| Frazier Life Sciences XII, L.P. | 0.10% | 110,554 |
| FHMLS XII, L.P. | 0.10% | 110,554 |
| FHMLS XII, L.L.C. | 0.10% | 110,554 |
Source
Related
- Braveheart Bio, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Braveheart Bio, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Sep 10, 2026
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13D · AH Bio Fund IV, L.P. · Aug 14, 2026
- Form 4 · Andreessen Marc L · Aug 11, 2026
- Form 4 · Chimovits Erez · Aug 11, 2026